Additionally, metabolic alterations such as UTX deficiency-driven tyrosine secretion promote immunosuppressive microenvironments via epigenetic mechanisms, exemplifying the intricate interplay between cellular metabolism and PTMs in CRC progression [75]. The gene discussed is KDM6A; the disease is colorectal carcinoma.